These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16216506)

  • 1. 3-Arylpiperazinylethyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives as novel, high-affinity and selective alpha(1)-adrenoceptor ligands.
    Pittalà V; Romeo G; Salerno L; Siracusa MA; Modica M; Materia L; Mereghetti I; Cagnotto A; Mennini T; Marucci G; Angeli P; Russo F
    Bioorg Med Chem Lett; 2006 Jan; 16(1):150-3. PubMed ID: 16216506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 3-arylpiperazinylalkylpyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as novel, potent, and selective alpha1-adrenoceptor ligands.
    Patanè E; Pittalà V; Guerrera F; Salerno L; Romeo G; Siracusa MA; Russo F; Manetti F; Botta M; Mereghetti I; Cagnotto A; Mennini T
    J Med Chem; 2005 Apr; 48(7):2420-31. PubMed ID: 15801833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and molecular modeling of 1H-pyrrolopyrimidine-2,4-dione derivatives as ligands for the α1-adrenoceptors.
    Pittalà V; Siracusa MA; Modica MN; Salerno L; Pedretti A; Vistoli G; Cagnotto A; Mennini T; Romeo G
    Bioorg Med Chem; 2011 Sep; 19(17):5260-76. PubMed ID: 21802308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [[(Arylpiperazinyl)alkyl]thio]thieno[2,3-d]pyrimidinone derivatives as high-affinity, selective 5-HT1A receptor ligands.
    Modica M; Santagati M; Russo F; Parotti L; De Gioia L; Selvaggini C; Salmona M; Mennini T
    J Med Chem; 1997 Feb; 40(4):574-85. PubMed ID: 9046348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha1-adrenoceptor antagonists. 6. Structural optimization of pyridazinone-arylpiperazines. Study of the influence on affinity and selectivity of cyclic substituents at the pyridazinone ring and alkoxy groups at the arylpiperazine moiety.
    Betti L; Corelli F; Floridi M; Giannaccini G; Maccari L; Manetti F; Strappaghetti G; Botta M
    J Med Chem; 2003 Jul; 46(16):3555-8. PubMed ID: 12877594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
    J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands.
    Siracusa MA; Salerno L; Modica MN; Pittalà V; Romeo G; Amato ME; Nowak M; Bojarski AJ; Mereghetti I; Cagnotto A; Mennini T
    J Med Chem; 2008 Aug; 51(15):4529-38. PubMed ID: 18598015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.
    Romeo G; Materia L; Manetti F; Cagnotto A; Mennini T; Nicoletti F; Botta M; Russo F; Minneman KP
    J Med Chem; 2003 Jul; 46(14):2877-94. PubMed ID: 12825930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α₁-Adrenoceptor and serotonin 5-HT(1A) receptor affinity of homobivalent 4-aminoquinoline compounds: an investigation of the effect of linker length.
    Chen J; Murad AK; Wakelin LP; Denny WA; Griffith R; Finch AM
    Biochem Pharmacol; 2013 May; 85(10):1534-41. PubMed ID: 23524075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors.
    Andrić D; Roglić G; Sukalović V; Soskić V; Kostić-Rajacić S
    Eur J Med Chem; 2008 Aug; 43(8):1696-705. PubMed ID: 18006194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.
    Sorbi C; Franchini S; Tait A; Prandi A; Gallesi R; Angeli P; Marucci G; Pirona L; Poggesi E; Brasili L
    ChemMedChem; 2009 Mar; 4(3):393-9. PubMed ID: 19152363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
    Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
    Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin.
    Handzlik J; Maciag D; Kubacka M; Mogilski S; Filipek B; Stadnicka K; Kieć-Kononowicz K
    Bioorg Med Chem; 2008 Jun; 16(11):5982-98. PubMed ID: 18490167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
    López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
    J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for α₁-adrenoceptor subtypes.
    Romeo G; Materia L; Modica MN; Pittalà V; Salerno L; Siracusa MA; Manetti F; Botta M; Minneman KP
    Eur J Med Chem; 2011 Jul; 46(7):2676-90. PubMed ID: 21514979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro binding of N-phenyl piperazine analogs as potential dopamine D3 receptor ligands.
    Chu W; Tu Z; McElveen E; Xu J; Taylor M; Luedtke RR; Mach RH
    Bioorg Med Chem; 2005 Jan; 13(1):77-87. PubMed ID: 15582454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
    Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of 1-aralkyl-4-benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent sigma ligands.
    Costantino L; Gandolfi F; Sorbi C; Franchini S; Prezzavento O; Vittorio F; Ronsisvalle G; Leonardi A; Poggesi E; Brasili L
    J Med Chem; 2005 Jan; 48(1):266-73. PubMed ID: 15634021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.
    Ortega R; Raviña E; Masaguer CF; Areias F; Brea J; Loza MI; López L; Selent J; Pastor M; Sanz F
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1773-8. PubMed ID: 19217777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.